Summary
Weight loss is the main symptom of so-called tumor cachexia. The pathogenetic mechanisms underlying cachexia are poorly understood; however, it appears that enhanced formation of cytokines such as interferon-γ and tumor necrosis factor-α are involved. In 94 patients suffering from hematological neoplasias we compared body weight changes with serum neopterin, tryptophan, and kynurenine. Biochemical changes, the formation of neopterin, the degradation of tryptophan are closely related to interferon-γ activity. The majority of our patients had increased neopterin and decreased tryptophan concentrations. Weight loss was seen particularly in patients with higher neopterin and lower tryptophan values. An association between higher neopterin levels and greater weight loss was apparent at study entry and during the follow-up of patients. Our data support the concept that weight loss is closely linked to endogenous interferon-γ activity.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- NHL:
-
non-Hodgkin's lymphoma
- HD:
-
Hodgkin's disease
- MM:
-
multiple myeloma
- MGUS:
-
monoclonal gammopathy of unknown significance
- IFN-γ:
-
interferon-γ
- TNF-α:
-
tumor necrosis factor-α
References
Balkwill F, Burke F, Talbot D, Taverniere J, Osborne R, Naylor S, Durbin H, Fiers W (1987) Evidence for tumour necrosis factor/cachectin production in cancer. Lancet 11:1229–1232
Bonadonna G, Santoro A, Viviani S, Valagussa P (1988) Treatment strategies for Hodgkin's disease. Sem Hematol 25:51–57
Brown RR, Lee CM, Kohler PC, Hank JA, Storer BE, Sondel PM (1989) Altered tryptophan and neopterin metabolism in cancer patients treated with recombinant interleukin 2. Cancer Res 49:4941–4944
Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report on the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860–1861
Denz HA, Fuchs D, Grünewald K, Huber H, Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H (1990) Urinary neopterin as a prognostic factor in haematological neoplasias. Pteridines 1:167–170
Denz H, Fuchs D, Huber H, Nachbaur D, Reibnegger G, Thaler J, Werner ER, Wachter H (1990) Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders. Eur J Haematol 44:186–189
Denz H, Landmann R, Orth B, Wachter H, Fuchs D (1992) Associations between the activation of macrophages, changes of iron metabolism and the degree of anaemia in patients with malignant disorders. Eur J Haematol 48:245–249
DeWyss WD, Begg C, Lavin PT, Band PR, Bennet JM, Bertino JR, Cohen MH, Douglass HO, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC (1980) Prognostic effect of weight-loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491–501
Durie BGM, Salmon SE (1975) A clinical staging system for multiple myeloma. Cancer 36:842–854
Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H (1988) Neopterin as a marker for activated cell-mediated immunity — application in HIV infection. Immunol Today 9:150–155
Fuchs D, Möller AA, Reibnegger G, Stöckle E, Werner E, Wachter H (1990) Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J AIDS 3:873–876
Fuchs D, Dotevall L, Hagberg L, Werner ER, Wachter H (1991) Kynurenine in cerebrospinal fluid of patients with Lyme neuroborreliosis. Immunol Infect Dis 1:271–274
Herrmann F, Cannistra SA, Griffin JD (1986) T cell-monocyte interactions in the production of humoral factors regulating human granulopoiesis in vitro. J Immunol 136:2856–2861
Klein B, Zhang XG, Jourdan M, Content J, Houssian F, Aarden L, Piechaczyk M, Bataille R (1989) Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73: 517–526
Matthys P, Dukmans R, Proost P, Van Damme J, Heremans H, Sobis H, Billiau A (1991) Severe cachexia in mice inoculated with interferon-gamma producing tumor cells. Int J Cancer 49:77–82
Metcalf D (1989) Haematopoietic growth factors 1. Lancet 1:825–827
Moldawer LL, Andersson C, Gelin J, Lundholm KG (1988) Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines. Am J Physiol 254:450–456
Morrison SD (1989) Cancer cachexia. In: Liotta LA (ed) Influence of tumor development on the host. Series Kaiser HE: Cancer growth and progression (3). Kluwer Academic Publishers, Dordrecht, pp 176–213
Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A, Lowry S (1988) Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation. J Exp Med 167:1211–1227
Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER (1989) Neopterin as marker of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 27:81–141
Wachter H, Fuchs D, Hausen A, Reibnegger G, Weiss G, Werner ER, Werner-Felmayer G (1992) Neopterin: biochemistry-methods-clinical Application. de Gruyter, Berlin
Werner ER, Bitterlich G, Fuchs D, Hausen A, Reibnegger G, Szabo G, Dierich MP, Wachter H (1987) Human macrophages degrade tryptophan upon induction by interferon gamma. Life Sci 41:273–280
Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H (1987) Simultaneous determination of neopterin and creatinine in serum with solid phase extraction and on-line elution liquid chromatography. Clin Chem 33:2028–2033
Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H (1989) Tumor necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Biol Chem Hoppe Seyler 370:1063–1069
Wright SC, Jewett A, Misuyasu R, Bonavida B (1988) Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J Immunol 141:99–104
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Denz, H., Orth, B., Weiss, G. et al. Weight loss in patients with hematological neoplasias is associated with immune system stimulation. Clin Investig 71, 37–41 (1993). https://doi.org/10.1007/BF00210961
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00210961